Searching Content indexed under Antitrust, EU Competition by Troutman Sanders LLP ordered by Published Date Descending.
Links to Result pages
Antitrust Risks To Private Equity Firms And Institutional Investors With Common Ownership Of Competitors
Common ownership of stock by large institutional investors has been identified by federal advisors as a "potential area" for additional regulation.
United States
22 Mar 2017
HSR Transaction And Filing Fee Thresholds Adjusted
The Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") requires parties to stock and asset transactions that satisfy specified jurisdictional thresholds to provide the Federal Trade Commission...
United States
17 Feb 2017
FERC Ordered To Participate In Full Civil Trial To Affirm Prior Market Manipulation Penalty
On July 21, 2016, the U.S. District Court for the District of Massachusetts ("District Court") determined that review of a FERC-issued penalty for alleged market manipulation must be treated as an "ordinary civil action"...
United States
28 Jul 2016
HSR Civil Penalty Skyrockets
Under HSR, parties to mergers and other acquisitions (equity or assets) meeting certain jurisdictional tests and not otherwise exempted must file notification with the Federal Trade Commission...
United States
20 Jul 2016
FERC Issues Show Cause Order Against Total Gas & Power And Its Employees For Alleged Cross-Market Manipulation
On April 28, 2016, FERC issued an Order to Show Cause and Notice of Proposed Penalty ("Order to Show Cause") against Total Gas & Power North America, Inc.
United States
4 May 2016
FTC Commissioner Brill To Resign
Commissioner Julie Brill with the Federal Trade Commission recently announced that she will step down at the end of this month to enter private practice.
United States
31 Mar 2016
The DOJís Generic Drug Antitrust Investigation May Be Just Beginning
Late last month, generic pharmaceutical companies in the United States received a signal that the Department of Justice's ("DOJ") Antitrust Division may be widening the scope of its federal investigation...
United States
22 Apr 2015
New York Attorney Generalís Product Hopping Lawsuit Raises Novel Issues Under The Antitrust Laws
Product hopping accusations continue to make the headlines, most recently after the Attorney General for the State of New York (the "AG") brought an antitrust lawsuit against Actavis, PLC and its subsidiary Forest Laboratories, LLC (collectively "Forest") based on their marketing plans for Namenda ģ, a hugely successful drug approved for the treatment of Alzheimerís disease.
United States
21 Nov 2014
Links to Result pages